UBS lowered the firm’s price target on Oracle to $135 from $140 and keeps a Buy rating on the shares. Oracle didn’t deliver the expected upside for Q1, and most key metrics were in-line and the Q2 revenue guidance of 7% at the midpoint fell short of the firm’s estimates, but UBS remains confident in the “OCI upside” bull case, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on ORCL: